Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

DUSP22-rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK/STAT surrogate markers.

Onaindia A, de Villambrosía SG, Prieto-Torres L, Rodríguez-Pinilla SM, Montes-Moreno S, González-Vela C, Piris MA.

Haematologica. 2019 Apr;104(4):e158-e162. doi: 10.3324/haematol.2018.205880. Epub 2018 Oct 25. No abstract available.

2.

Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements.

Luchtel RA, Dasari S, Oishi N, Pedersen MB, Hu G, Rech KL, Ketterling RP, Sidhu J, Wang X, Katoh R, Dogan A, Kip NS, Cunningham JM, Sun Z, Baheti S, Porcher JC, Said JW, Jiang L, Hamilton-Dutoit SJ, Møller MB, Nørgaard P, Bennani NN, Chng WJ, Huang G, Link BK, Facchetti F, Cerhan JR, d'Amore F, Ansell SM, Feldman AL.

Blood. 2018 Sep 27;132(13):1386-1398. doi: 10.1182/blood-2018-03-838524. Epub 2018 Aug 9.

PMID:
30093402
3.

Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.

King RL, Dao LN, McPhail ED, Jaffe ES, Said J, Swerdlow SH, Sattler CA, Ketterling RP, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Gibson SE, Ondrejka SL, Nicolae A, Macon WR, Dasari S, Parrilla Castellar E, Feldman AL.

Am J Surg Pathol. 2016 Jan;40(1):36-43. doi: 10.1097/PAS.0000000000000500.

4.

Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes.

Mélard P, Idrissi Y, Andrique L, Poglio S, Prochazkova-Carlotti M, Berhouet S, Boucher C, Laharanne E, Chevret E, Pham-Ledard A, De Souza Góes AC, Guyonnet-Duperat V, Bibeyran A, Moreau-Gaudry F, Vergier B, Beylot-Barry M, Merlio JP, Cappellen D.

Oncotarget. 2016 Oct 18;7(42):68734-68748. doi: 10.18632/oncotarget.11930.

5.

Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.

Hapgood G, Ben-Neriah S, Mottok A, Lee DG, Villa D, Sehn LH, Connors JM, Gascoyne RD, Feldman AL, Farinha P, Steidl C, Scott DW, Slack GW, Savage KJ.

Br J Haematol. 2019 Mar 14. doi: 10.1111/bjh.15860. [Epub ahead of print] No abstract available.

PMID:
30873584
6.

Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.

Xing X, Feldman AL.

Adv Anat Pathol. 2015 Jan;22(1):29-49. doi: 10.1097/PAP.0000000000000047. Review.

PMID:
25461779
7.

Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma.

Xing X, Flotte TJ, Law ME, Blahnik AJ, Chng WJ, Huang G, Knudson RA, Ketterling RP, Porcher JC, Ansell SM, Sidhu J, Dogan A, Feldman AL.

Appl Immunohistochem Mol Morphol. 2015 Sep;23(8):580-9. doi: 10.1097/PAI.0000000000000118.

8.

Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.

Chen J, Zhang Y, Petrus MN, Xiao W, Nicolae A, Raffeld M, Pittaluga S, Bamford RN, Nakagawa M, Ouyang ST, Epstein AL, Kadin ME, Del Mistro A, Woessner R, Jaffe ES, Waldmann TA.

Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3975-3980. doi: 10.1073/pnas.1700682114. Epub 2017 Mar 29.

9.

Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia.

Tasian SK, Doral MY, Borowitz MJ, Wood BL, Chen IM, Harvey RC, Gastier-Foster JM, Willman CL, Hunger SP, Mullighan CG, Loh ML.

Blood. 2012 Jul 26;120(4):833-42. doi: 10.1182/blood-2011-12-389932. Epub 2012 Jun 8.

10.

A novel PTPN1 splice variant upregulates JAK/STAT activity in classical Hodgkin lymphoma cells.

Zahn M, Marienfeld R, Melzner I, Heinrich J, Renner B, Wegener S, Mießner A, Barth TF, Dorsch K, Brüderlein S, Möller P.

Blood. 2017 Mar 16;129(11):1480-1490. doi: 10.1182/blood-2016-06-720516. Epub 2017 Jan 12.

11.

Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas.

Haralambieva E, Pulford KA, Lamant L, Pileri S, Roncador G, Gatter KC, Delsol G, Mason DY.

Br J Haematol. 2000 Jun;109(3):584-91.

PMID:
10886208
12.

Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features.

Onaindia A, Montes-Moreno S, Rodríguez-Pinilla SM, Batlle A, González de Villambrosía S, Rodríguez AM, Alegre V, Bermúdez GM, González-Vela C, Piris MA.

Histopathology. 2015 May;66(6):846-55. doi: 10.1111/his.12529. Epub 2015 Feb 4.

PMID:
25131361
13.
14.

ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.

Falini B, Bigerna B, Fizzotti M, Pulford K, Pileri SA, Delsol G, Carbone A, Paulli M, Magrini U, Menestrina F, Giardini R, Pilotti S, Mezzelani A, Ugolini B, Billi M, Pucciarini A, Pacini R, Pelicci PG, Flenghi L.

Am J Pathol. 1998 Sep;153(3):875-86.

16.

Molecular Pathogenesis of Peripheral T Cell Lymphoma.

Sakata-Yanagimoto M, Chiba S.

Curr Hematol Malig Rep. 2015 Dec;10(4):429-37. doi: 10.1007/s11899-015-0289-7. Review.

PMID:
26431836
17.

Indolent ALK-negative anaplastic large-cell lymphoma, DUSP22 rearranged, with an unusual immunophenotype in a human immunodeficiency virus patient.

Chapman J, Vega F.

Histopathology. 2017 Jun;70(7):1173-1175. doi: 10.1111/his.13163. Epub 2017 Mar 10. No abstract available.

PMID:
28042680
18.

The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus.

Heim MH.

J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):75-120. Review.

PMID:
10071751
19.

Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).

Oishi N, Miranda RN, Feldman AL.

Aesthet Surg J. 2019 Jan 31;39(Supplement_1):S14-S20. doi: 10.1093/asj/sjy311.

PMID:
30715169
20.

A comprehensive comparative analysis of the histomorphological features of ALK-rearranged lung adenocarcinoma based on driver oncogene mutations: frequent expression of epithelial-mesenchymal transition markers than other genotype.

Kim H, Jang SJ, Chung DH, Yoo SB, Sun P, Jin Y, Nam KH, Paik JH, Chung JH.

PLoS One. 2013 Oct 23;8(10):e76999. doi: 10.1371/journal.pone.0076999. eCollection 2013.

Supplemental Content

Support Center